JP7508354B2 - Paper treatment agent and paper using the same - Google Patents
Paper treatment agent and paper using the same Download PDFInfo
- Publication number
- JP7508354B2 JP7508354B2 JP2020203837A JP2020203837A JP7508354B2 JP 7508354 B2 JP7508354 B2 JP 7508354B2 JP 2020203837 A JP2020203837 A JP 2020203837A JP 2020203837 A JP2020203837 A JP 2020203837A JP 7508354 B2 JP7508354 B2 JP 7508354B2
- Authority
- JP
- Japan
- Prior art keywords
- paper
- treatment agent
- component
- mass
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003795 chemical substances by application Substances 0.000 claims description 95
- -1 ester compound Chemical class 0.000 claims description 45
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 38
- 229930195729 fatty acid Natural products 0.000 claims description 38
- 239000000194 fatty acid Substances 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 150000004665 fatty acids Chemical class 0.000 claims description 21
- 239000004166 Lanolin Substances 0.000 claims description 20
- 229940039717 lanolin Drugs 0.000 claims description 20
- 235000019388 lanolin Nutrition 0.000 claims description 20
- 150000005846 sugar alcohols Polymers 0.000 claims description 19
- 239000002736 nonionic surfactant Substances 0.000 claims description 14
- 239000000539 dimer Substances 0.000 claims description 11
- 235000019271 petrolatum Nutrition 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000004264 Petrolatum Substances 0.000 claims description 5
- 229940066842 petrolatum Drugs 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 230000003020 moisturizing effect Effects 0.000 description 18
- 238000011156 evaluation Methods 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 9
- 230000006866 deterioration Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000004909 Moisturizer Substances 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 230000001333 moisturizer Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- VJZWIFWPGRIJSN-XRHABHTOSA-N dilinoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O VJZWIFWPGRIJSN-XRHABHTOSA-N 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000007639 printing Methods 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 229920003169 water-soluble polymer Polymers 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000005215 alkyl ethers Chemical class 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 238000007646 gravure printing Methods 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000003871 white petrolatum Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- LYOKOJQBUZRTMX-UHFFFAOYSA-N 1,3-bis[[1,1,1,3,3,3-hexafluoro-2-(trifluoromethyl)propan-2-yl]oxy]-2,2-bis[[1,1,1,3,3,3-hexafluoro-2-(trifluoromethyl)propan-2-yl]oxymethyl]propane Chemical compound FC(F)(F)C(C(F)(F)F)(C(F)(F)F)OCC(COC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)(COC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)COC(C(F)(F)F)(C(F)(F)F)C(F)(F)F LYOKOJQBUZRTMX-UHFFFAOYSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- CAKGLMPBYAPFCR-UWBMNBDUSA-N Bemisiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 CAKGLMPBYAPFCR-UWBMNBDUSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 229940099367 lanolin alcohols Drugs 0.000 description 1
- 238000007644 letterpress printing Methods 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 235000019828 potassium polyphosphate Nutrition 0.000 description 1
- 229940098424 potassium pyrophosphate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Landscapes
- Sanitary Thin Papers (AREA)
- Paper (AREA)
Description
本発明は、紙類処理剤とそれを用いた紙類に関する。 The present invention relates to a paper treatment agent and paper using the same.
従来、保湿剤を主成分とする紙類処理剤で紙類を処理することで、通常のドライティッシュやトイレットペーパー等に比べて紙類にしっとり感と柔らかさを付与した製品が知られている。その代表的な製品であるローションティッシュは、ティッシュ原紙に紙類処理剤としてローション剤を塗布した保湿ティッシュであり、しっとりとして、柔らかさのある風合いで使用感が大きく向上することから、花粉症、インフルエンザ対策等の冬場の季節商品として普及が進み、近年では、鼻かみ用途中心から日常用途へ拡大し、通年化しつつある。それに伴い、湿度環境の異なる夏場と冬場で風合いが変わり、品質を一定に保つことができないという問題が生じており、低湿度環境でも風合いを維持できることが求められていた。 Conventionally, there are known products that treat paper with paper treatment agents whose main component is a moisturizing agent, thereby giving the paper a moisturizing feel and softness compared to ordinary dry tissues, toilet paper, etc. A representative product is lotion tissue, which is a moisturizing tissue made by applying a lotion as a paper treatment agent to tissue base paper. Since it has a moist and soft texture and greatly improves the feeling of use, it has become popular as a seasonal product in winter to prevent hay fever and influenza, and in recent years, its use has expanded from being used mainly for blowing noses to everyday use, and it is becoming a year-round product. As a result, the texture changes between summer and winter, which have different humidity environments, and the quality cannot be maintained at a constant level, and there has been a demand for a product that can maintain its texture even in low humidity environments.
保湿ティッシュの保湿剤には、グリセリンやポリエチレングリコール(PEG)等の多価アルコール、特に、安価で安全な優れた保湿剤であるグリセリンが使用される場合が多い。この保湿剤によって紙類の吸湿性、保湿性を強化し、紙類にしっとり柔らかな風合いを付与している。人がものに触れたときに感じる材質感や感触としての風合いは、保湿ティッシュの使用感に大きな影響を与え、商品の付加価値となる最も重要な品質になっている。 Moisturizing tissues often use polyhydric alcohols such as glycerin or polyethylene glycol (PEG), especially glycerin, which is an inexpensive, safe and excellent moisturizing agent. This humectant enhances the moisture absorption and moisture retention of paper, giving the paper a moist and soft texture. The texture of the material and the feel that people get when they touch it have a major impact on the feel of moisturizing tissues when used, and is the most important quality that adds value to the product.
ローションティッシュは保湿剤であるグリセリンが水分を取りこむこと、柔軟成分を配合することによって柔らかくなっており、保湿ティッシュの柔らかさは、塗布紙水分量の増加によるパルプ間水素結合の減少によって発現している。保湿剤が取り込む水分量は外環境の湿度に依存しており、低湿度環境下ではティッシュから水分が失われ、パルプ間の水素結合が再構築されるため、高湿度環境下に比べ紙は硬くなってしまう。これによる低湿度環境下での風合い劣化が問題となっていた。 Lotion tissues become soft by the moisture absorption of the moisturizer glycerin and by incorporating softening ingredients, and the softness of moisturizing tissues is achieved by the reduction in hydrogen bonds between the pulp due to the increased moisture content of the coated paper. The amount of moisture absorbed by the moisturizer depends on the humidity of the external environment, and in low-humidity environments moisture is lost from the tissue and the hydrogen bonds between the pulp are reconstructed, making the paper harder than in high-humidity environments. This causes deterioration of the texture in low-humidity environments, which has been an issue.
保湿ティッシュの保湿剤には、この保湿剤に加えて、柔らかさや表面の感触(滑らかさ)といった風合いを向上させるために、界面活性剤や、炭化水素、エステル等の油性成分、増粘剤など様々な基剤を配合している。界面活性剤は、主に風合いの特徴を左右する成分となり、柔らかさを付与し得る。油性成分は、主に風合いの変化を左右する成分となり、滑らかさを付与し得る。しかし、このような風合いを付与しつつ、低湿度環境下での風合い劣化を防ぐことは困難であった。 In addition to the moisturizer, moisturizing tissues contain various bases such as surfactants, oily components such as hydrocarbons and esters, and thickeners to improve texture, such as softness and surface feel (smoothness). Surfactants are the components that mainly determine the characteristics of the texture and can impart softness. Oily components are the components that mainly determine changes in texture and can impart smoothness. However, it has been difficult to impart such texture while preventing deterioration of the texture in low humidity environments.
更に、主成分の保湿剤と、これらの基剤を均一に混合し、製造から輸送、塗布されるまでの間、塗布時のムラの発生等を抑制し安定な状態を保つためには、乳化する必要があるが、保湿剤をベースとした乳化系の調製は非常に困難である上に、乳化を整えるための基剤バランスと風合いを向上させるための基剤バランスを両立させることも非常に困難である。一方、低粘度の紙類処理剤は、移送が容易でハンドリング性が良く、処理紙に対する処理剤付着量の管理が平易で、操業性が良好となる。従って粘度増加による操業性の悪化を回避することが求められている。 Furthermore, emulsification is required to uniformly mix the main moisturizing agent with these bases and maintain a stable state from production to transportation and application, while preventing unevenness during application. However, preparing an emulsion system based on a moisturizing agent is extremely difficult, and it is also extremely difficult to achieve both a base balance for adjusting the emulsion and a base balance for improving texture. On the other hand, low-viscosity paper treatment agents are easy to transport and handle, and the amount of treatment agent attached to the treated paper is easy to manage, resulting in good operability. Therefore, there is a need to avoid the deterioration of operability caused by increased viscosity.
このように、低湿度環境下での風合い劣化を防ぎつつ、処理剤の経時安定性が良好で、粘度も適正に保つことができる技術が望まれていた。 As such, there was a demand for technology that could prevent deterioration of texture in low humidity environments, while also providing good stability over time and maintaining appropriate viscosity of the treatment agent.
これらの課題に対し、様々な対策が講じられてきた。例えば、ゲル組成物の薬剤を用いた技術(特許文献1)、水溶性高分子の吸水性を利用し、しっとり感の向上を図る技術(特許文献2)、油類物質と水溶性ワックスを使用し、柔らかさや摩擦の低減を図る技術(特許文献3)、ショ糖脂肪酸エステル、分岐アルコール、直鎖の高級脂肪酸や高級アルコール等の成分を配合し、低湿度環境下での柔らかさや、肌触りの向上等を図る技術(特許文献4~8)が提案されている。 Various measures have been taken to address these issues. For example, a technology that uses a drug in a gel composition (Patent Document 1), a technology that uses the water-absorbing properties of water-soluble polymers to improve moisturizing (Patent Document 2), a technology that uses oily substances and water-soluble waxes to reduce softness and friction (Patent Document 3), and a technology that incorporates ingredients such as sucrose fatty acid esters, branched alcohols, linear higher fatty acids, and higher alcohols to improve softness and texture in low humidity environments (Patent Documents 4 to 8).
しかしながら、特許文献1では紙類へのゲル組成物の均一な処理は煩雑な工程を伴う。また、ゲル組成物は移送が困難であることが問題となっていた。特許文献2では、水溶性高分子は均一分散に時間と労力を要し、薬剤製造上の工程が複雑化した。また、水溶性高分子は著しい増粘を引き起こすため、配合量を制限せざるを得なかった。特許文献3では、水溶性ワックスは粘度が高く、薬剤の流動性や均一塗布性を損ない、操業性を悪化させるという問題があった。特許文献4~7では、上記の諸成分は保湿剤中に配合しやすいという利点があり、低湿度環境下での柔らかさの保持に寄与し得るものの、その効果は十分でなかった。特許文献8は多価アルコールではなく油性成分を主成分としており、その風合いは柔軟性やしっとり感がなく、水分の保持力も不十分であった。 However, in Patent Document 1, uniform application of the gel composition to paper involves complicated processes. In addition, the gel composition is difficult to transport, which is a problem. In Patent Document 2, the water-soluble polymer requires time and effort to be uniformly dispersed, complicating the drug manufacturing process. In addition, the water-soluble polymer causes significant thickening, so the amount of the water-soluble polymer must be limited. In Patent Document 3, the water-soluble wax has a high viscosity, which impairs the fluidity and uniform application of the drug, and deteriorates operability. In Patent Documents 4 to 7, the above-mentioned components have the advantage of being easily incorporated into the moisturizing agent, and can contribute to maintaining softness in a low-humidity environment, but the effect is not sufficient. Patent Document 8 uses oily components rather than polyhydric alcohols as the main components, and the texture is not flexible or moist, and the moisture retention is insufficient.
本発明は、以上のような事情に鑑みてなされたものであり、紙類に柔軟性としっとり感を付与し、かつ処理された紙類の湿度環境に起因した水分の低下による風合いの劣化を低減することができ、更に、紙類処理剤の経時安定性が良好で、粘度も適正に保つことができる紙類処理剤とそれを用いた紙類を提供することを課題としている。 The present invention was made in consideration of the above circumstances, and aims to provide a paper treatment agent that imparts flexibility and a moist feel to paper, reduces deterioration in texture due to a decrease in moisture content caused by a humid environment of the treated paper, and further has good stability over time and can maintain an appropriate viscosity, as well as paper using the same.
上記の課題を解決するために、本発明者は鋭意検討した結果、多価アルコールを主成分として配合することによって、紙類にはしっとり感、柔軟性が付与されると共に、抱水性を持つ油性成分を配合することによって、低湿度環境下でも水分を維持し、しっとり感、柔軟性を維持することができ、更に、これと組み合わせてHLBが特定範囲の非イオン性界面活性剤を配合することによって、紙類処理剤に安定性良く抱水性油性成分を配合することができ、粘度も適正に保つことができることを見出し、本発明を完成するに至った。 In order to solve the above problems, the inventors conducted extensive research and discovered that by incorporating a polyhydric alcohol as the main component, it is possible to impart a moist feel and flexibility to paper, and by incorporating an oil-based component with water-holding properties, it is possible to maintain moisture and maintain the moist feel and flexibility even in low humidity environments, and further, by combining this with a nonionic surfactant with an HLB in a specific range, it is possible to incorporate the water-holding oil-based component with good stability into the paper treatment agent and maintain the appropriate viscosity, which led to the completion of the present invention.
即ち本発明の紙類処理剤は、(A)多価アルコールを主成分として含有する紙類処理剤であって、
(B)前記処理剤の水分以外の成分全量に対して0.40~25質量%のワセリン、ラノリン、ダイマー酸を含む脂肪酸と多価アルコールとのエステル化合物、ラノリンアルコール、及びラノリン脂肪酸から選ばれる少なくとも1種の抱水性油性成分、及び(C)HLBが12以上の非イオン性界面活性剤を含有することを特徴としている。
本発明の紙類は、前記紙類処理剤で処理したことを特徴としている。
That is, the paper treating agent of the present invention is a paper treating agent containing (A) a polyhydric alcohol as a main component,
The treatment agent is characterized by containing (B) at least one water-containing oil component selected from petrolatum, lanolin, an ester compound of a fatty acid including a dimer acid and a polyhydric alcohol, lanolin alcohol, and lanolin fatty acid, in an amount of 0.40 to 25% by mass based on the total amount of the components other than water in the treatment agent, and (C) a nonionic surfactant having an HLB of 12 or more.
The paper of the present invention is characterized by being treated with the paper treating agent.
本発明によれば、紙類に柔軟性としっとり感を付与し、かつ処理された紙類の湿度環境に起因した水分の低下による風合いの劣化を低減することができ、更に、紙類処理剤の経時安定性が良好で、粘度も適正に保つことができる。 The present invention can impart flexibility and a moist feel to paper and reduce deterioration in texture due to a decrease in moisture content caused by the humid environment of the treated paper. Furthermore, the paper treatment agent has good stability over time and can maintain an appropriate viscosity.
以下に、本発明を詳細に説明する。 The present invention is described in detail below.
本発明の紙類処理剤は、(A)多価アルコールを主成分として含有する紙類処理剤であって、(B)抱水性油性成分及び(C)非イオン性界面活性剤を必須としている。以下、これらをそれぞれ(A)成分、(B)成分、(C)成分ともいう。 The paper treatment agent of the present invention is a paper treatment agent containing (A) a polyhydric alcohol as the main component, and (B) a water-holding oil component and (C) a nonionic surfactant are essential. Hereinafter, these will be referred to as component (A), component (B), and component (C), respectively.
多価アルコールである(A)成分を主成分として配合することによって、紙類にはしっとり感、柔軟性が付与される。抱水性を持つ油性成分である(B)成分を配合することによって、低湿度環境下でも水分を維持し、しっとり感、柔軟性を維持できる。HLBが12以上の非イオン性界面活性剤である(C)成分を配合することによって、紙類処理剤に安定性良く抱水性油性成分(B)を配合することができ、粘度も適正に保つことができる。 By blending component (A), a polyhydric alcohol, as the main component, the paper is given a moist feel and flexibility. By blending component (B), an oil-based component with water-holding properties, the paper can retain moisture even in low humidity environments, and maintain a moist feel and flexibility. By blending component (C), a nonionic surfactant with an HLB of 12 or more, the water-holding oil-based component (B) can be blended stably into the paper treatment agent, and the viscosity can also be maintained appropriately.
本発明の紙類処理剤において、(A)成分の多価アルコールは、紙類の吸湿性、保湿性を強化し、紙類にしっとり感、柔軟性を付与する保湿剤であり、紙類処理剤の主成分である。 In the paper treatment agent of the present invention, the polyhydric alcohol of component (A) is a moisturizing agent that enhances the hygroscopicity and moisture retention of paper and gives the paper a moist feel and flexibility, and is the main component of the paper treatment agent.
ここで主成分とは、紙類処理剤の原料である各添加成分の中で、(A)成分を最も多い質量で配合することを意味する。その中でも、(A)成分の含有量は、水を除く紙類処理剤の全量に対して50質量%以上が好ましく、70質量%以上がより好ましく、75質量%がより好ましく、80質量%以上が更に好ましい。なお、紙類処理剤の配合成分は水分を除いた有効成分の値を示している。 Here, the main component means that, among the various additive components that are the raw materials of the paper treatment agent, component (A) is blended in the largest amount by mass. Among them, the content of component (A) is preferably 50% by mass or more, more preferably 70% by mass or more, more preferably 75% by mass or more, and even more preferably 80% by mass or more, based on the total amount of the paper treatment agent excluding water. Note that the blended components of the paper treatment agent indicate the values of the active ingredients excluding water.
本発明に用いられる(A)成分の多価アルコールとしては、例えば、グリセリン、ジグリセリン、トリグリセリン、ポリグリセリン、1,2-プロパンジオール、1,3-プロパンジオール、ジプロピレングリコール、ポリプロピレングリコール、1,3-ブタンジオール、1,4-ブタンジオール、1,2-ペンタンジオール、1,2-ヘキサンジオール、エチレングリコール、ジエチレングリコール、トリエチレングリコール、ポリエチレングリコール、ポリオキシエチレングリセリンエーテル、イソプレングリコール、ペンタエリスリトール、トリメチロールプロパン等が挙げられる。また、糖アルコール類や糖類であってもよく、糖アルコール類としては、例えば、ソルビトール、イノシトール、グルコシルトレハロース、キシリトール、エリスリトール、マンニトール、ラクチトール、フルクトース、オリゴ糖アルコール、マルチトール、還元パラチノース、還元水飴、還元澱粉加水分解物等が挙げられる。糖類としては、例えば、果糖、ブドウ糖、乳糖、キシロース、プシコース、麦芽糖、水飴、オリゴ糖、マルトース、トレハロース、ラクトース、パラチニット、ショ糖、異性化糖、イソマルトオリゴ糖、フラクトオリゴ糖、ガラクトオリゴ糖、キシロオリゴ糖、乳果オリゴ糖、大豆オリゴ糖、ラフィノース、ステビア、甘草、サッカリン、アスパルテーム、アセスルファムK、スクラロース等が挙げられる。これらは1種単独で使用してもよく、2種以上を組み合わせて使用してもよい。 Examples of the polyhydric alcohol of component (A) used in the present invention include glycerin, diglycerin, triglycerin, polyglycerin, 1,2-propanediol, 1,3-propanediol, dipropylene glycol, polypropylene glycol, 1,3-butanediol, 1,4-butanediol, 1,2-pentanediol, 1,2-hexanediol, ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, polyoxyethylene glycerin ether, isoprene glycol, pentaerythritol, trimethylolpropane, etc. Also, sugar alcohols and sugars may be used, and examples of sugar alcohols include sorbitol, inositol, glucosyl trehalose, xylitol, erythritol, mannitol, lactitol, fructose, oligosaccharide alcohol, maltitol, reduced palatinose, reduced starch syrup, reduced starch hydrolysate, etc. Examples of sugars include fructose, glucose, lactose, xylose, psicose, maltose, starch syrup, oligosaccharides, maltose, trehalose, lactose, palatinite, sucrose, isomerized sugar, isomaltooligosaccharides, fructooligosaccharides, galactooligosaccharides, xylooligosaccharides, lactofructose oligosaccharides, soybean oligosaccharides, raffinose, stevia, licorice, saccharin, aspartame, acesulfame K, sucralose, etc. These may be used alone or in combination of two or more.
これらの中でも、グリセリンが好ましい。保湿剤としてグリセリンを使用する場合、保湿剤全量に対するグリセリンの割合は80質量%以上が好ましく、90質量%以上がより好ましい。グリセリンと併用する保湿剤としては、例えば、ソルビトール等が挙げられる。 Among these, glycerin is preferred. When glycerin is used as a moisturizer, the ratio of glycerin to the total amount of moisturizer is preferably 80% by mass or more, and more preferably 90% by mass or more. Examples of moisturizers to be used in combination with glycerin include sorbitol.
本発明の紙類処理剤において、保湿剤としては、(A)成分の多価アルコール以外の成分を(A)成分と併用してもよい。このような保湿剤としては、例えば、アミノ酸類、吸湿性を有するアルカリ類・酸類とそれらの塩類が挙げられる。アミノ酸類としては、例えば、グリシン、バリン、ロイシン、イソロイシン、セリン、トレオニン、フェニルアラニン、アルギニン、リジン、アスパラギン酸、グルタミン酸、シスチン、システイン、メチオニン、トリプトファン等が挙げられる。吸湿性を有するアルカリ類・酸類とそれらの塩類としては、例えば、パンテテイン-S-スルホン酸塩、トリメチルグリシン、ベタイン、ピロリン酸、ピロリン酸ナトリウム、コンドロイチン硫酸塩、ピロリン酸カリウム、ヒアルロン酸、ヒアルロン酸ナトリウム、メタリン酸ナトリウム、ポリリン酸カリウム、ピロリドンカルボン酸ナトリウム、乳酸ナトリウム、塩化ナトリウム、塩化カルシウム、アルギン酸ナトリウム、ポリアクリル酸ナトリウム等が挙げられる。これらは1種単独で使用してもよく、2種以上を組み合わせて使用してもよい。 In the paper treatment agent of the present invention, a component other than the polyhydric alcohol of component (A) may be used in combination with component (A) as a moisturizing agent. Examples of such moisturizing agents include amino acids, hygroscopic alkalis and acids, and their salts. Examples of amino acids include glycine, valine, leucine, isoleucine, serine, threonine, phenylalanine, arginine, lysine, aspartic acid, glutamic acid, cystine, cysteine, methionine, tryptophan, and the like. Examples of hygroscopic alkalis and acids and their salts include pantetheine-S-sulfonate, trimethylglycine, betaine, pyrophosphate, sodium pyrophosphate, chondroitin sulfate, potassium pyrophosphate, hyaluronic acid, sodium hyaluronate, sodium metaphosphate, potassium polyphosphate, sodium pyrrolidone carboxylate, sodium lactate, sodium chloride, calcium chloride, sodium alginate, sodium polyacrylate, and the like. These may be used alone or in combination of two or more.
本発明の紙類処理剤において、(B)成分は、ワセリン、ラノリン、ダイマー酸を含む脂肪酸と多価アルコールとのエステル化合物、ラノリンアルコール、及びラノリン脂肪酸から選ばれる少なくとも1種の抱水性油性成分である。(B)成分は抱水性を持ち、これを配合することによって、低湿度環境下でも水分を維持し、しっとり感、柔軟性を維持できる。また(B)成分は、処理した紙類における表面の感触(滑らかさ)といった風合いを向上させる。 In the paper treatment agent of the present invention, component (B) is at least one water-holding oil component selected from petrolatum, lanolin, ester compounds of fatty acids including dimer acid and polyhydric alcohols, lanolin alcohol, and lanolin fatty acid. Component (B) has water-holding properties, and by incorporating this component, it is possible to maintain moisture even in low-humidity environments, and to maintain a moist feel and flexibility. Component (B) also improves the texture, such as the feel (smoothness) of the surface of the treated paper.
ワセリンとしては、石油から得た炭化水素類の混合物を脱色して精製したものが挙げられる。典型的な例として、分岐鎖を有するパラフィン及び脂環式炭化水素を含む。具体的には、例えば、日本薬局方に記載の白色ワセリン、小堺製薬株式会社の白色ワセリンS、日興リカ株式会社の高精製ワセリン サンホワイトP-150、サンホワイトP-200、日清オイリオグループ株式会社のノムコートW、Sonneborn LLCのWP-2395、White Protopet 1S、Super White Protopet、Perfecta、クローダジャパン株式会社のクロラータムV等が挙げられる。 Examples of petrolatum include those obtained by decolorizing and refining a mixture of hydrocarbons obtained from petroleum. Typical examples include branched-chain paraffin and alicyclic hydrocarbons. Specific examples include white petrolatum described in the Japanese Pharmacopoeia, White Petrolatum S from Kosakai Pharmaceutical Co., Ltd., highly refined petrolatum Sunwhite P-150 and Sunwhite P-200 from Nikko Rica Corporation, Nomcoat W from Nisshin Oillio Group, Ltd., WP-2395, White Protopet 1S, Super White Protopet, Perfecta from Sonneborn LLC, and Chloratum V from Croda Japan Co., Ltd.
ラノリンとしては、ウールに覆われた動物の皮脂腺から分泌される蝋が挙げられる。具体的には、例えば、日本精化株式会社のEcolano LN-C、液状ラノリン、Ecolano LN-E、Ecolano LL-E、精製ラノリン等が挙げられる。 Lanolin is a wax secreted from the sebaceous glands of animals covered in wool. Specific examples include Ecolano LN-C, liquid lanolin, Ecolano LN-E, Ecolano LL-E, and refined lanolin, all manufactured by Nippon Fine Chemical Co., Ltd.
ダイマー酸を含む脂肪酸と多価アルコールとのエステル化合物としては、例えば、ダイマージリノール酸を含む脂肪酸と多価アルコールとのエステル化合物が挙げられる。このエステル化合物は、共重合体(コポリマーやオリゴマー)であってもよい。脂肪酸としては、ダイマージリノール酸に加えてそれ以外の脂肪酸、例えばカルボキシ基を1つ有する長鎖脂肪酸を含んでいてもよい。多価アルコールとしては、(ポリ)グリセリン、(ポリ)アルキレングリコール等が挙げられる。具体的には、例えば、イソステアリン酸ポリグリセリル-2/ダイマージリノール酸)コポリマー、ダイマージリノール酸/ステアリン酸/ヒドロキシステアリン酸)ポリグリセリル、(ジエチレングリコール/ダイマージリノール酸)コポリマー等を用いることができ、市販品としては、高級アルコール工業株式会社のハイルーセントISDA、NIKKOL GS-WHO、株式会社ファンケルの保湿性オリゴマーエステルD/DC等が挙げられる。これらの中でも、ダイマージリノール酸を含む脂肪酸とポリグリセリンとのエステル化合物、例えばダイマージリノール酸/ステアリン酸/ヒドロキシステアリン酸)ポリグリセリルが好ましい。 Examples of ester compounds of fatty acids containing dimer acid and polyhydric alcohols include ester compounds of fatty acids containing dimer dilinoleic acid and polyhydric alcohols. The ester compounds may be copolymers (copolymers or oligomers). The fatty acids may contain other fatty acids in addition to dimer dilinoleic acid, such as long-chain fatty acids having one carboxy group. Examples of polyhydric alcohols include (poly)glycerin and (poly)alkylene glycol. Specifically, for example, polyglyceryl-2 isostearate/dimer dilinoleic acid copolymer, polyglyceryl dimer dilinoleic acid/stearic acid/hydroxystearic acid, (diethylene glycol/dimer dilinoleic acid) copolymer, etc. can be used. Commercially available products include High Lucent ISDA and NIKKOL GS-WHO from Kokyu Alcohol Kogyo Co., Ltd., and Moisturizing Oligomer Ester D/DC from FANCL Corporation. Among these, ester compounds of fatty acids including dimer dilinoleic acid and polyglycerin, such as polyglyceryl dimer dilinoleate/stearic acid/hydroxystearic acid, are preferred.
ラノリンアルコールとしては、ラノリンの加水分解により得られる高級アルコールとステロールの混合物が挙げられる。具体的には、例えば、日本精化株式会社のラノリンアルコールA、EcolanoAL-E、クローダジャパン株式会社のSUPER HARTOLAN等が挙げられる。 Lanolin alcohols include mixtures of higher alcohols and sterols obtained by hydrolysis of lanolin. Specific examples include Lanolin Alcohol A and EcolanoAL-E from Nippon Fine Chemical Co., Ltd., and SUPER HARTOLAN from Croda Japan Co., Ltd.
ラノリン脂肪酸は、ラノリンの加水分解により得られる脂肪酸混合物が挙げられる。具体的には、例えば、日本精化株式会社のラノリン脂肪酸LIV、ラノリン脂肪酸DO、ラノリン脂肪酸W、ラノリン脂肪酸ソフト、Ecolano FW-HHL、クローダジャパン株式会社の18MEA等が挙げられる。 Lanolin fatty acids include fatty acid mixtures obtained by hydrolysis of lanolin. Specific examples include Lanolin Fatty Acid LIV, Lanolin Fatty Acid DO, Lanolin Fatty Acid W, Lanolin Fatty Acid Soft, Ecolano FW-HHL from Nippon Fine Chemical Co., Ltd., and 18MEA from Croda Japan Co., Ltd.
本発明の紙類処理剤において、(B)成分の含有量は、水を除いた処理剤全量に対して0.40~25質量%である。全体的な各効果の発現、特に、低湿度環境下でも水分を維持し、しっとり感、柔軟性を維持できることを考慮すると、水を除いた処理剤全量に対して0.40質量%以上であり、0.50質量%以上が好ましく、0.60質量%以上がより好ましい。低湿度環境下でも水分を維持し、しっとり感、柔軟性を維持できること、また紙類処理剤に安定性良く抱水性油性成分を配合することができ、粘度も適正に保つことができることを考慮すると、水を除いた処理剤全量に対して25質量%以下であり、特に紙類処理剤に安定性良く抱水性油性成分を配合することができることを考慮すると、水を除いた処理剤全量に対して20質量%以下が好ましく、15質量%以下がより好ましく、13質量%以下が更に好ましく、10質量%以下が最も好ましい。 In the paper treatment agent of the present invention, the content of component (B) is 0.40 to 25% by mass based on the total amount of the treatment agent excluding water. Considering the overall expression of each effect, particularly the ability to maintain moisture and moisturizing and flexibility even in a low humidity environment, the content is 0.40% by mass or more based on the total amount of the treatment agent excluding water, preferably 0.50% by mass or more, and more preferably 0.60% by mass or more. Considering the ability to maintain moisture and moisturizing and flexibility even in a low humidity environment, the ability to stably blend water-holding oil components into the paper treatment agent, and the ability to maintain appropriate viscosity, the content is 25% by mass or less based on the total amount of the treatment agent excluding water, and particularly considering the ability to stably blend water-holding oil components into the paper treatment agent, the content is 20% by mass or less based on the total amount of the treatment agent excluding water, more preferably 15% by mass or less, even more preferably 13% by mass or less, and most preferably 10% by mass or less.
本発明の紙類処理剤において、(C)成分は、HLBが12以上の非イオン性界面活性剤である。(C)成分を配合することによって、紙類処理剤に安定性良く抱水性油性成分(B)を配合することができ、紙類処理剤の経時安定性が良好となる。また粘度の増加を抑制し適正な低粘度に保つことができるので、移送が容易でハンドリング性が良く、処理紙に対する処理剤付着量の管理が平易で、操業性が良好となる。
(C)成分のHLBは、13以上18以下が好ましく、14以上16以下がより好ましい。
In the paper treatment agent of the present invention, component (C) is a nonionic surfactant with an HLB of 12 or more. By incorporating component (C), the water-containing oil component (B) can be incorporated stably into the paper treatment agent, improving the stability of the paper treatment agent over time. In addition, the increase in viscosity can be suppressed and the viscosity can be kept appropriately low, making the agent easy to transport and easy to handle, and the amount of the agent attached to the treated paper can be easily controlled, improving operability.
The HLB of the component (C) is preferably 13 or more and 18 or less, and more preferably 14 or more and 16 or less.
HLB(Hydrophilic-Lipophilic Balance)は、界面活性剤の疎水性と親水性のバランスを表す数値であり、非イオン性界面活性剤ではグリフィン法による値が参照される。グリフィン法では、親水基の式量と分子量を元に、HLB=20×(親水基の重量%)で求められる。 HLB (Hydrophilic-Lipophilic Balance) is a number that indicates the balance between hydrophobicity and hydrophilicity of a surfactant, and for nonionic surfactants, the value obtained by the Griffin method is used. In the Griffin method, it is calculated based on the formula weight and molecular weight of the hydrophilic group, as HLB = 20 x (weight % of hydrophilic group).
非イオン性界面活性剤としては、例えば、エチレングリコール脂肪酸エステル、プロピレングリコール脂肪酸エステル、モノグリセリン脂肪酸エステル、ジグリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、有機酸モノグリセリド、ソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンヒマシ油、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアリルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリエーテル変性シリコーン、ポリオキシエチレン脂肪酸アルカノールアミド、及び脂肪酸アルカノールアミド等が挙げられる。これらは1種単独で使用してもよく、2種以上を組み合わせて使用してもよい。 Examples of nonionic surfactants include ethylene glycol fatty acid esters, propylene glycol fatty acid esters, monoglycerin fatty acid esters, diglycerin fatty acid esters, polyglycerin fatty acid esters, organic acid monoglycerides, sorbitan fatty acid esters, sucrose fatty acid esters, polyoxyethylene fatty acid esters, polyoxyethylene glycerin fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, polyoxyethylene alkyl ethers, polyoxyethylene allyl ethers, polyoxyethylene polyoxypropylene alkyl ethers, polyether modified silicones, polyoxyethylene fatty acid alkanolamides, and fatty acid alkanolamides. These may be used alone or in combination of two or more.
これらの中でも、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ショ糖脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレンアルキルエーテルが好ましい。 Among these, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene fatty acid esters, polyoxyethylene hydrogenated castor oil, sucrose fatty acid esters, polyglycerin fatty acid esters, and polyoxyethylene alkyl ethers are preferred.
本発明の紙類処理剤において、(C)成分の含有量は、全体的な各効果の発現を考慮すると、水を除いた処理剤全量に対して0.1~40質量%が好ましい。紙類処理剤に安定性良く抱水性油性成分を配合することができ、粘度も適正に保つことができることを考慮すると、水を除いた処理剤全量に対して0.1質量%以上が好ましく、0.2質量%以上がより好ましく、0.4質量%以上が更に好ましく、0.5質量%以上が特に好ましい。粘度を適正に保つことができることを考慮すると、水を除いた処理剤全量に対して40質量%以下が好ましく、特に粘度を適正に保つことができることを考慮すると、水を除いた処理剤全量に対して20質量%以下が好ましく、18質量%以下がより好ましく、15質量%以下が更に好ましい。 In the paper treatment agent of the present invention, the content of component (C) is preferably 0.1 to 40% by mass based on the total amount of the treatment agent excluding water, taking into consideration the overall expression of each effect. In consideration of the ability to stably blend the water-holding oil component into the paper treatment agent and to maintain the viscosity appropriately, the content is preferably 0.1% by mass or more based on the total amount of the treatment agent excluding water, more preferably 0.2% by mass or more, even more preferably 0.4% by mass or more, and particularly preferably 0.5% by mass or more. In consideration of the ability to maintain the viscosity appropriately, the content is preferably 40% by mass or less based on the total amount of the treatment agent excluding water, and in particular, in consideration of the ability to maintain the viscosity appropriately, the content is preferably 20% by mass or less based on the total amount of the treatment agent excluding water, more preferably 18% by mass or less, and even more preferably 15% by mass or less.
本発明の紙類処理剤は、全体的な各効果の発現を考慮すると、(A)成分の含有量が、水を除いた処理剤全量に対して80質量%以上、(B)成分の含有量が、水を除いた処理剤全量に対して0.5~20質量%、(C)成分の含有量が、水を除いた処理剤全量に対して0.2~20質量%であることが特に好ましい態様である。 In consideration of the overall manifestation of each effect, it is particularly preferred that the content of component (A) is 80% by mass or more based on the total amount of the treatment agent excluding water, the content of component (B) is 0.5 to 20% by mass based on the total amount of the treatment agent excluding water, and the content of component (C) is 0.2 to 20% by mass based on the total amount of the treatment agent excluding water.
本発明の紙類処理剤は、全体的な各効果の発現を考慮すると、(C’)HLB12未満の非イオン性界面活性剤を含有し、(C’)成分と前記(C)成分との質量比((C’)/(C))が、0.01~10であることが好ましい。下限は粘度を適正に保つ点で0.03以上がより好ましい。上限は系全体のバランスを整え、乳化の安定性を高める点で3.0以下がより好ましい。 In consideration of the overall expression of each effect, the paper treatment agent of the present invention preferably contains (C') a nonionic surfactant with an HLB of less than 12, and the mass ratio of the (C') component to the (C) component ((C')/(C)) is 0.01 to 10. The lower limit is more preferably 0.03 or more in terms of maintaining an appropriate viscosity. The upper limit is more preferably 3.0 or less in terms of balancing the entire system and increasing the stability of the emulsion.
(C’)成分のHLBは、上記(C)成分として記載した方法で求めることができる。(C’)成分としては、例えば、ソルビタン脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンヒマシ油、モノグリセリン脂肪酸エステル等が挙げられる。 The HLB of component (C') can be determined by the method described above for component (C). Examples of component (C') include sorbitan fatty acid esters, polyoxyethylene alkyl ethers, polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, and monoglycerin fatty acid esters.
本発明の紙類処理剤において、(B)成分と(C)成分との質量比((B)/(C))は、全体的な各効果の発現を考慮すると、0.005~99が好ましい。下限は粘度を適正に保つ点で0.03以上がより好ましい。上限は乳化の安定性を高める点で、10以下がより好ましく、4.0以下が更に好ましく、2.0以下が最も好ましい。 In the paper treatment agent of the present invention, the mass ratio of component (B) to component (C) ((B)/(C)) is preferably 0.005 to 99, taking into consideration the overall expression of each effect. The lower limit is more preferably 0.03 or more in terms of maintaining an appropriate viscosity. The upper limit is more preferably 10 or less, even more preferably 4.0 or less, and most preferably 2.0 or less in terms of increasing the stability of the emulsion.
本発明において、紙類処理剤には、本発明の効果を損なわない範囲内において、上記以外の他の成分を原料として添加することができる。このような他の成分としては、特に限定されないが、例えば、水、非イオン性界面活性剤、カチオン性界面活性剤、アニオン性界面活性剤、両性イオン界面活性剤、油性成分、増粘剤、防カビ剤、防腐剤、消泡剤、香料、色素類、pH調整剤、エキス類、抗酸化剤、抗炎症剤、無機鉱物、無機塩、水溶性高分子等が挙げられる。 In the present invention, other components than those mentioned above can be added as raw materials to the paper treatment agent within the range that does not impair the effects of the present invention. Such other components are not particularly limited, but examples include water, nonionic surfactants, cationic surfactants, anionic surfactants, zwitterionic surfactants, oily components, thickeners, antifungal agents, preservatives, defoamers, fragrances, dyes, pH adjusters, extracts, antioxidants, anti-inflammatory agents, inorganic minerals, inorganic salts, water-soluble polymers, etc.
油性成分としては、例えば、固形パラフィンや流動パラフィン等の炭化水素類、油脂類、エステル類、シリコーン油類、ロウ類、ステロイド類等が挙げられる。これらは1種単独で使用してもよく、2種以上を組み合わせて使用してもよい。 Examples of oily components include hydrocarbons such as solid paraffin and liquid paraffin, oils and fats, esters, silicone oils, waxes, steroids, etc. These may be used alone or in combination of two or more.
水は、添加してもよく、添加しなくてもよいが、添加する場合には、紙類処理剤中の水分量が1~30質量%となるように添加されることが好ましく、3~25質量%となるように添加されることがより好ましく、5~20質量%となるように添加されることが更に好ましい。 Water may or may not be added, but if water is added, it is preferably added so that the moisture content in the paper treatment agent is 1-30% by mass, more preferably 3-25% by mass, and even more preferably 5-20% by mass.
本発明の紙類処理剤は、常法に従って各原料を均一に混合することによって製造することができ、例えば、各原料が溶解する温度で撹拌混合することにより得ることができる。 The paper treatment agent of the present invention can be produced by uniformly mixing the raw materials according to conventional methods, for example by stirring and mixing at a temperature at which the raw materials dissolve.
本発明の紙類処理剤は、(A)成分中に、(C)成分により(B)成分が均一に混合されていればよく、主成分である(A)成分に(B)成分や(C)成分が、溶融している状態でも、可溶化している状態でも、乳化している状態でも、分散している状態でもよい。 The paper treatment agent of the present invention is sufficient if component (B) is uniformly mixed in component (A) via component (C), and components (B) and (C) may be in a molten state, a solubilized state, an emulsified state, or a dispersed state in component (A), which is the main component.
本発明の紙類は、以上に説明した紙類処理剤で処理したものである。本発明の紙類処理剤で紙類を処理することにより、紙類に柔軟性としっとり感を付与し、かつ処理された紙類の湿度環境に起因した水分の低下による風合いの劣化を低減することができ、更に、紙類処理剤の経時安定性が良好で、粘度も適正に保つことができる。 The paper of the present invention is treated with the paper treatment agent described above. Treating paper with the paper treatment agent of the present invention imparts flexibility and a moist feel to the paper, and reduces deterioration of the texture of the treated paper due to a decrease in moisture content caused by the humid environment. Furthermore, the paper treatment agent has good stability over time and can maintain an appropriate viscosity.
紙類としては、例えば、ティッシュペーパー、トイレットペーパー、フェイシャルティッシュ、ポケットティッシュ、紙ハンカチ、紙タオル等が挙げられる。 Examples of paper products include tissue paper, toilet paper, facial tissue, pocket tissue, paper handkerchiefs, paper towels, etc.
紙類の坪量は、1~50g/m2が好ましく、5~20g/m2がより好ましい。ply数(原紙の積層枚数)は、1~5が好ましく、2~3がより好ましい。 The basis weight of the paper is preferably 1 to 50 g/m 2 , and more preferably 5 to 20 g/m 2. The number of plies (the number of layers of base paper) is preferably 1 to 5, and more preferably 2 to 3.
紙類処理剤で紙類を処理する方法としては、例えば、紙類に塗布する方法等が挙げられる。紙類に塗布する方法としては、例えば、転写、噴霧等が挙げられる。これらの方法で紙類に塗布する方式としては、例えば、フレキソ印刷方式、グラビア印刷方式、スプレー方式、ローターダンプニング方式等が挙げられる。フレキソ印刷方式では、凸版印刷機の一種であるフレキソ印刷機を使用し、表面を彫刻したゴムや合成樹脂等の刷版を装着したローラーで紙類処理剤を紙類に転写する。グラビア印刷方式では、凹版印刷機の一種であるグラビア印刷機を使用し、表面に製版を施した金属のシリンダで装着したローラーで紙類処理剤を紙類に転写する。スプレー方式では、圧縮空気によりノズルから紙類処理剤を霧状に紙類へ噴霧する。ローターダンプニング方式では、高速回転する円盤で紙類処理剤を霧状に紙類へ噴霧する。 Methods for treating paper with paper treatment agents include, for example, coating the paper. Examples of methods for coating paper include transfer and spraying. Examples of methods for coating paper using these methods include flexographic printing, gravure printing, spraying, and rotor dampening. In the flexographic printing method, a flexographic printing machine, which is a type of letterpress printing machine, is used to transfer the paper treatment agent to the paper with a roller equipped with a printing plate made of rubber or synthetic resin with an engraved surface. In the gravure printing method, a gravure printing machine, which is a type of intaglio printing machine, is used to transfer the paper treatment agent to the paper with a roller equipped with a metal cylinder with a plate made on its surface. In the spray method, the paper treatment agent is sprayed in a mist form from a nozzle using compressed air. In the rotor dampening method, the paper treatment agent is sprayed in a mist form onto the paper with a disk rotating at high speed.
紙類への紙類処理剤の塗布量は、水分を除いた有効分で1~7g/m2が好ましく、1.5~6g/m2がより好ましい。 The amount of the paper treatment agent applied to the paper is preferably 1 to 7 g/m 2 , more preferably 1.5 to 6 g/m 2 , in terms of the effective amount excluding moisture.
以下に、実施例により本発明を更に詳細に説明するが、本発明はこれらの実施例に限定されるものではない。
(1)紙類処理剤の調製
次の手順により紙類処理剤を調製した。
ビーカーに各配合原料を表1、表2に記載した添加量で仕込み、各原料が溶解する温度で攪拌混合し、紙類処理剤を調製した。表1に示す各成分の配合量は、有姿量が水分を含む場合、水分を除いた有効分を示している。
The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples.
(1) Preparation of Paper Treatment Agent A paper treatment agent was prepared according to the following procedure.
The raw materials were charged in the amounts shown in Tables 1 and 2 into a beaker and mixed under stirring at a temperature at which each raw material dissolved to prepare a paper treatment agent. The amount of each component shown in Table 1 indicates the effective amount excluding water when the actual amount contains water.
(2)塗布紙の作製
上記の方法により得られた紙類処理剤を水に溶解させて有効分25質量%の処理液を調製した。各処理液を、ドライティッシュ(ply数2、坪量12~13g/m2)の両面に処理剤の有効分が25質量%±3%となるように均一に噴霧処理し、その後、3時間風乾させた。
(2) Preparation of Coated Paper The paper treatment agents obtained above were dissolved in water to prepare treatment solutions with an active content of 25% by mass. Each treatment solution was sprayed evenly onto both sides of a dry tissue (ply count 2, basis weight 12-13 g/ m2 ) so that the active content of the treatment agent was 25% by mass ±3%, and then the tissue was air-dried for 3 hours.
(3)評価
上記において作製した各実施例及び比較例の塗布紙について以下の評価を行った。
[40%R.H.、25℃平衡時水分率(%)、25質量%塗布紙]
冬場の低湿度環境の基準として湿度40%R.H.、25℃の環境を作った。一定時間ごとに作製した塗布紙10枚(5組)の質量を測定し、質量の変化がなくなった時点で水分率が平衡に達したと判断した。塗布紙および原紙の絶乾質量は80℃で90分間乾燥させた後の質量とする。
平衡時の水分率(%)=(平衡時の質量(g)-塗布紙の絶乾質量(g))/原紙の絶乾質量(g)
(3) Evaluation The coated papers of the Examples and Comparative Examples prepared above were evaluated as follows.
[40% RH, 25°C equilibrium moisture content (%), 25% by weight coated paper]
As a standard low humidity environment for winter, an environment of 40% RH and 25°C was created. The masses of 10 sheets (5 sets) of coated paper prepared at regular intervals were measured, and when there was no more change in mass, it was determined that the moisture content had reached equilibrium. The bone dry masses of the coated paper and base paper were taken as the masses after drying at 80°C for 90 minutes.
Moisture content at equilibrium (%)=(mass at equilibrium (g)−bone dry mass of coated paper (g))/bone dry mass of base paper (g)
[低湿度での柔軟性、しっとり感(B値)]
上記と同様の手順により、湿度40%R.H.、25℃での調湿を経て作製した塗布紙に対し、試験機器として純曲げ試験機KES-FB2-S(カトーテック(株))を用い、塗布紙2枚(1組)の曲げ柔らかさを示すB値を求めた。
評価基準
◎:B値が0.06未満
〇+:B値が0.06以上、0.065未満
〇:B値が0.065以上、0.07未満
×:B値が0.07以上
[Flexibility and moist feeling at low humidity (B value)]
The coated papers were prepared by the same procedure as above, after conditioning at a humidity of 40% RH and 25°C. A pure bending tester KES-FB2-S (Kato Tech Co., Ltd.) was used as the testing equipment to determine the B value, which indicates the bending softness of two sheets of the coated papers (one set).
Evaluation criteria: ⊚: B value is less than 0.06; ◯+: B value is 0.06 or more and less than 0.065; ◯: B value is 0.065 or more and less than 0.07; ×: B value is 0.07 or more
[低湿度での柔軟性、しっとり感(官能評価)]
官能評価として、上記と同様の手順により、湿度40%R.H.、25℃での調湿を経て作製した塗布紙を、熟練したパネル10名により、以下の評価点に基づいて1~3点のいずれかの点数で評価し、その平均値より以下の基準で評価した。
評価点
3点:柔軟性及びしっとり感を感じる。
2点:やや柔軟性としっとり感を感じる。
1点:いずれも感じない。
評価基準
◎:パネル10名の平均点が2.5点以上
〇+:パネル10名の平均点が2.0点以上2.5点未満
○:パネル10名の平均点が1.5点以上2.0点未満
×:パネル10名の平均点が1.5点未満
[Softness and moist feeling at low humidity (sensory evaluation)]
For the sensory evaluation, coated papers prepared by the same procedure as above, after conditioning at a humidity of 40% RH and 25°C, were evaluated by 10 experienced panelists on a scale of 1 to 3 based on the following evaluation points, and the average value was used to evaluate the papers according to the following criteria.
Evaluation score: 3 points: Feels soft and moist.
2 points: Feels somewhat flexible and moist.
1 point: Neither felt.
Evaluation criteria: ◎: The average score of the 10 panelists is 2.5 points or more. ◯+: The average score of the 10 panelists is 2.0 points or more and less than 2.5 points. ○: The average score of the 10 panelists is 1.5 points or more and less than 2.0 points. ×: The average score of the 10 panelists is less than 1.5 points.
[処理剤の安定性]
(1)で調製した各実施例及び比較例の処理剤について、調製直後および室温で1か月静置して保存した時の状態を確認し、実際の使用に適することを考慮し以下の基準で評価した。
評価基準
◎:調製直後も一か月後も均一な状態を維持
〇+:わずかな状態の変化(粘度や外観)はあるものの一か月後も均一な状態を維持
〇:やや状態の変化はあるものの一か月後も均一な状態を維持
×:調製直後から不均一、又は一か月間均一な状態を保てない
[Stability of treatment agent]
The condition of the treatment agents prepared in each of the Examples and Comparative Examples in (1) was checked immediately after preparation and after being left to stand at room temperature for one month, and evaluated according to the following criteria, taking into consideration suitability for practical use.
Evaluation criteria: ◎: Maintains a uniform state immediately after preparation and one month later. 〇+: Maintains a uniform state one month later, although there is a slight change in state (viscosity and appearance). 〇: Maintains a uniform state one month later, although there is a slight change in state. ×: Not uniform immediately after preparation, or does not maintain a uniform state for one month.
[処理剤の粘度]
(1)で調製した各実施例及び比較例の処理剤について、B型粘度計を用いて60rpm、40℃において粘度を測定し、操業性を考慮し以下の基準で評価した。
評価基準
◎:処理剤の粘度が800mPa・s未満
〇+:処理剤の粘度が800mPa・s以上1500mPa・s未満
○:処理剤の粘度が1500mPa・s以上2000mPa・s未満
×:処理剤の粘度が2000mPa・s以上又は測定不能(均一な状態を保てない)
[Viscosity of treatment agent]
The viscosity of the treatment agents prepared in each of the Examples and Comparative Examples in (1) was measured at 60 rpm and 40° C. using a Brookfield viscometer, and the viscosity was evaluated according to the following criteria, taking into account the operability.
Evaluation criteria: ◎: Viscosity of the treatment agent is less than 800 mPa·s; ◯+: Viscosity of the treatment agent is 800 mPa·s or more and less than 1500 mPa·s; ○: Viscosity of the treatment agent is 1500 mPa·s or more and less than 2000 mPa·s; ×: Viscosity of the treatment agent is 2000 mPa·s or more or cannot be measured (unable to maintain a uniform state)
各実施例及び比較例の配合と各項目の評価結果を表1、表2に示す。表1、表2において各成分の配合量は質量部で示している。
上記した表1、表2の各評価項目において、◎、○+、○は課題解決の点で望ましい範囲であり、かつ、これらの間には効果発現において有意な差がある。×は、各項目のうち1つでも含まれる場合は課題解決上不可と判断した。
表1、表2において、(C)成分及び(C’)成分のHLBは同表に記載した。
The formulations of the examples and comparative examples and the evaluation results of each item are shown in Tables 1 and 2. In Tables 1 and 2, the formulation amount of each component is shown in parts by mass.
In the evaluation items in Tables 1 and 2, ◎, ○+, and ○ are in a desirable range in terms of solving the problem, and there is a significant difference in the effect between them. × means that if even one of the items is included, it is judged that it is impossible to solve the problem.
In Tables 1 and 2, the HLB values of components (C) and (C') are shown in the same tables.
表1、表2より、実施例1~17では、(A)多価アルコールを主成分とし、(B)抱水性油性成分を特定範囲の量で配合し、かつ(C)HLBが12以上の非イオン性界面活性剤を配合する紙類処理剤を用いた。これらは紙類に柔軟性としっとり感を付与し、かつ処理された紙類の湿度環境に起因した水分の低下による風合いの劣化を低減することができ、更に、紙類処理剤の経時安定性が良好で、粘度も適正に保つことができた。実施例及び比較例の評価では客観的指標としての水分率が4.5%以上で官能評価が◎、4.4%で〇+、4.2%で〇、4.1%以下で×となり、塗布紙の水分率と官能評価に高い相関があることを確認した。風合いに関しては更に、実施例及び比較例の評価では試験機器を用いた客観的指標としてのB値と官能評価にも高い相関があることを確認した。(C)成分の含有量が特定範囲である場合や、(B)成分と(C)成分との質量比((B)/(C))が特定範囲である場合、(C’)HLB12未満の非イオン性界面活性剤を含有し(C’)成分と(C)成分との質量比((C’)/(C))が特定範囲である場合には、効果の発現がより顕著となる傾向を確認した。比較例1、4は(B)成分が少なく、比較例7は(B)成分を配合しなかったが、比較例4、7のように抱水性を持たない油性成分であるパラフィンを加えても、低湿度での柔軟性、しっとり感等の所望の効果は得られなかった。比較例8は(B)成分の配合量が多く、安定に乳化できず、また高粘度となった。比較例6、9は(C)成分に代えて他の界面活性剤を用いたが、(B)成分を安定に乳化できず、また高粘度となった。比較例2、3、5は油性成分を多く含むなど(A)成分を主成分としない配合、またHLBが12未満の非イオン性界面活性剤、高級脂肪酸、高級アルコール、有機酸のような成分を用いた配合であるが、所望の効果は得られなかった。 From Tables 1 and 2, in Examples 1 to 17, a paper treatment agent was used that contains (A) a polyhydric alcohol as the main component, (B) a water-containing oil component in a specific range of amounts, and (C) a nonionic surfactant with an HLB of 12 or more. These give the paper flexibility and a moist feel, and can reduce the deterioration of the texture of the treated paper due to a decrease in moisture caused by the humidity environment. Furthermore, the paper treatment agent has good stability over time and can maintain an appropriate viscosity. In the evaluation of the Examples and Comparative Examples, the sensory evaluation was rated as ◎ when the moisture content was 4.5% or more as an objective index, 〇+ when it was 4.4%, 〇 when it was 4.2%, and × when it was 4.1% or less, confirming that there is a high correlation between the moisture content of the coated paper and the sensory evaluation. Regarding the texture, it was also confirmed that there is a high correlation between the B value as an objective index using a test device and the sensory evaluation in the evaluation of the Examples and Comparative Examples. It was confirmed that the effect tends to be more pronounced when the content of the (C) component is within a specific range, when the mass ratio ((B)/(C)) of the (B) component to the (C) component is within a specific range, or when a nonionic surfactant (C') with an HLB of less than 12 is contained and the mass ratio ((C')/(C)) of the (C') component to the (C) component is within a specific range. Comparative Examples 1 and 4 contained a small amount of the (B) component, and Comparative Example 7 did not contain the (B) component, but even when paraffin, an oily component that does not have water-holding capacity, was added as in Comparative Examples 4 and 7, the desired effects such as flexibility at low humidity and moist feeling were not obtained. Comparative Example 8 contained a large amount of the (B) component, and the emulsion could not be stably emulsified and the viscosity was high. Comparative Examples 6 and 9 used other surfactants instead of the (C) component, but the emulsion could not be stably emulsified and the viscosity was high. Comparative Examples 2, 3, and 5 were formulations that did not primarily contain component (A), such as those that contained a large amount of oily components, and formulations that used components such as nonionic surfactants with an HLB of less than 12, higher fatty acids, higher alcohols, and organic acids, but did not achieve the desired effect.
Claims (6)
(B)水を除いた前記処理剤全量に対して0.40~25質量%のワセリン、ラノリン、ダイマー酸を含む脂肪酸と多価アルコールとのエステル化合物、ラノリンアルコール、及びラノリン脂肪酸から選ばれる少なくとも1種の抱水性油性成分、及び(C)HLBが12以上の非イオン性界面活性剤を含有する紙類処理剤。 (A) A paper treatment agent containing a polyhydric alcohol as a main component,
A paper treatment agent comprising (B) at least one water-containing oil component selected from petrolatum, lanolin, an ester compound of a fatty acid including a dimer acid and a polyhydric alcohol, lanolin alcohol, and lanolin fatty acid, in an amount of 0.40 to 25 mass% based on the total amount of the treatment agent excluding water, and (C) a nonionic surfactant having an HLB of 12 or more.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020203837A JP7508354B2 (en) | 2020-12-09 | 2020-12-09 | Paper treatment agent and paper using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020203837A JP7508354B2 (en) | 2020-12-09 | 2020-12-09 | Paper treatment agent and paper using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022091186A JP2022091186A (en) | 2022-06-21 |
JP7508354B2 true JP7508354B2 (en) | 2024-07-01 |
Family
ID=82067332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020203837A Active JP7508354B2 (en) | 2020-12-09 | 2020-12-09 | Paper treatment agent and paper using the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7508354B2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008080028A (en) | 2006-09-28 | 2008-04-10 | Daio Paper Corp | Sanitary paper |
JP2010265562A (en) | 2009-05-14 | 2010-11-25 | Lion Corp | Agent for treating thin paper and thin paper |
JP2013044071A (en) | 2011-08-26 | 2013-03-04 | Nippon Paper Crecia Co Ltd | Sanitary paper and method for producing the same |
JP2020045605A (en) | 2019-12-04 | 2020-03-26 | ミヨシ油脂株式会社 | Method for producing paper treatment agent and method for improving texture of paper |
-
2020
- 2020-12-09 JP JP2020203837A patent/JP7508354B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008080028A (en) | 2006-09-28 | 2008-04-10 | Daio Paper Corp | Sanitary paper |
JP2010265562A (en) | 2009-05-14 | 2010-11-25 | Lion Corp | Agent for treating thin paper and thin paper |
JP2013044071A (en) | 2011-08-26 | 2013-03-04 | Nippon Paper Crecia Co Ltd | Sanitary paper and method for producing the same |
JP2020045605A (en) | 2019-12-04 | 2020-03-26 | ミヨシ油脂株式会社 | Method for producing paper treatment agent and method for improving texture of paper |
Also Published As
Publication number | Publication date |
---|---|
JP2022091186A (en) | 2022-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100542169B1 (en) | Soft Tissue Achieved by Applying a Solid Hydrophilic Lotion | |
TWI706069B (en) | Paper treatment agent and paper treating method | |
US9757322B2 (en) | Liquid cosmetic | |
TW201102106A (en) | Skin care preparation for external use | |
JP4833936B2 (en) | Tissue paper | |
EP3767030B1 (en) | Paper treatment agent | |
JP7508354B2 (en) | Paper treatment agent and paper using the same | |
JP6225712B2 (en) | Sanitary paper softener | |
JP7309972B1 (en) | Paper processing agent, paper using the same, and method for improving texture of paper | |
JP6747966B2 (en) | Method for producing paper treating agent and method for improving texture of paper | |
JP2022091699A (en) | Paper treatment agent, paper using the same, and method for promoting inactivation of virus using the same | |
CN1476324A (en) | Oil-based lotions for paper products | |
AU2023280611A1 (en) | Paper treatment agent and paper using same, and method for improving paper texture | |
JP2020045605A (en) | Method for producing paper treatment agent and method for improving texture of paper | |
JP6900562B2 (en) | Method of manufacturing paper treatment agent and method of improving the texture of paper | |
WO2024185166A1 (en) | Paper treatment agent, paper using same, and method for improving texture of paper | |
JP7546113B1 (en) | Oil-in-water emulsion cosmetics | |
JP6068787B2 (en) | Tissue paper manufacturing method | |
TW202436729A (en) | A paper treatment agent and papers using the same, and a method for improving the texture of papers | |
JP2008297318A (en) | Method for producing cosmetic sheet containing powder | |
TW201922210A (en) | Skin cosmetic | |
JPS62226911A (en) | Skin cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231110 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240618 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240619 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7508354 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |